Anti-IL-6R antibody [EPR24322-143]
- BOND RX™ Validated
- 20ul selling size
- RabMAb
- Recombinant
- What is this?
5
(1 Review)
|
(10 Publications)
Rabbit Recombinant Monoclonal IL-6R antibody. Suitable for ICC/IF, IP, WB, IHC-P and reacts with Human samples. Cited in 10 publications.
View Alternative Names
CD126, Interleukin-6 receptor subunit alpha, IL-6 receptor subunit alpha, IL-6R subunit alpha, IL-6R-alpha, IL-6RA, IL-6R 1, Membrane glycoprotein 80, gp80, IL6R
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-IL-6R antibody [EPR24322-143] (AB271042)
Immunohistochemical analysis of paraffin-embedded Human tonsil tissue labelling IL-6R with ab271042 at 1/2000 dilution (0.255 ug/ml) followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection). Cyoplasmics staining on human tonsil. The section was incubated with ab271042 for 30 minutes at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument Counterstained with Hematoxylin.
Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 minutes.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-IL-6R antibody [EPR24322-143] (AB271042)
Immunohistochemical analysis of paraffin-embedded Human placenta tissue labelling IL-6R with ab271042 at 1/2000 dilution (0.255 ug/ml) followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection). Cyoplasmics staining on human placenta (PMID : 25658637). The section was incubated with ab271042 for 30 minutes at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument Counterstained with Hematoxylin.
Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 minutes.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-IL-6R antibody [EPR24322-143] (AB271042)
Immunofluorescent analysis of 4% Paraformaldehyde-fixed, 0.1% TritonX-100 permeabilized U266B1 cells labelling IL-6R with ab271042 at 1/50 dilution, followed by ab150077 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) antibody at 1/1000 dilution (Green). Confocal image showing cytoplasmic staining in U266B1 cells. Negative control : K-562 (PMID : 8300137) is observed. ab195889 Anti-alpha Tubulin mouse monoclonal antibody - Microtubule Marker (Alexa Fluor® 594) was used to counterstain tubulin at 1/200 dilution (Red). The Nuclear counterstain was DAPI (Blue).
Secondary antibody only control : Secondary antibody is ab150077 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) at 1/1000 dilution.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-IL-6R antibody [EPR24322-143] (AB271042)
Immunohistochemical analysis of paraffin-embedded Human thyroid carcinoma tissue labelling IL-6R with ab271042 at 1/2000 dilution (0.255 ug/ml) followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection). Cyoplasmics staining on human thyroid carcinoma. The section was incubated with ab271042 for 30 minutes at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument Counterstained with Hematoxylin.
Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 minutes.
- IP
Supplier Data
Immunoprecipitation - Anti-IL-6R antibody [EPR24322-143] (AB271042)
IL-6R was immunoprecipitated from 0.35 mg U266B1 (human multiple myeloma B lymphocyte) whole cell lysate 10 ug with ab271042 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab271042 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP)(ab131366) was used at 1/5000 dilution.
Lane 1 : U266B1 (human multiple myeloma B lymphocyte) whole cell lysate 10 ug
Lane 2 : ab271042 IP in U266B1 whole cell lysate
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab271042 in U266B1 whole cell lysate
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 5.5 seconds
All lanes:
Immunoprecipitation - Anti-IL-6R antibody [EPR24322-143] (ab271042)
Predicted band size: 52 kDa
Observed band size: 70-80 kDa
false
- WB
Lab
Western blot - Anti-IL-6R antibody [EPR24322-143] (AB271042)
Blocking and diluting buffer and concentration : 5% NFDM/TBST
The observed MW is consistent with what has been described in the literature (PMID : 28276471, 21282511).
Negative control : K-562 (PMID : 8300137)
This blot was developed using a higher sensitivity ECL substrate.
Exposure time : 37 seconds
All lanes:
Western blot - Anti-IL-6R antibody [EPR24322-143] (ab271042) at 1/1000 dilution
Lane 1:
U266B1 (human multiple myeloma B lymphocyte) whole cell lysate at 20 µg
Lane 2:
K-562 (human chronic myelogenous leukemia lymphoblast) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 52 kDa
Observed band size: 70-80 kDa
false
Related conjugates and formulations (8)
-
Anti-IL-6R antibody [EPR24322-143] - BSA and Azide free
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-IL-6R antibody [EPR24322-143]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-IL-6R antibody [EPR24322-143]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-IL-6R antibody [EPR24322-143]
-
660 APC
APC Anti-IL-6R antibody [EPR24322-143]
-
578 PE
PE Anti-IL-6R antibody [EPR24322-143]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-IL-6R antibody [EPR24322-143]
-
775 Alexa Fluor® 750
Alexa Fluor® 750 Anti-IL-6R antibody [EPR24322-143]
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
IL-6 receptor function involves mediating the effects of IL-6 through its interaction with glycoprotein 130 (gp130) forming a signaling complex. This complex initiates intracellular pathways that lead to gene expression changes necessary for immune responses inflammation and hematopoiesis. When IL-6 binds IL-6R the complex formation with gp130 triggers downstream signaling that impacts cell growth differentiation and survival.
Pathways
IL-6R is central to the JAK/STAT signaling pathway one of the two main pathways activated by IL-6 signaling. It's also involved in the MAPK cascade contributing to cellular responses such as proliferation and differentiation. Through these pathways IL-6R interacts with other proteins like JAK kinases and STAT transcription factors coordinating cellular responses to external signals.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (10)
Recent publications for all applications. Explore the full list and refine your search
Antioxidants (Basel, Switzerland) 14: PubMed40867839
2025
Applications
Unspecified application
Species
Unspecified reactive species
BJC reports 3:49 PubMed40624140
2025
Applications
Unspecified application
Species
Unspecified reactive species
Respiratory research 26:180 PubMed40349069
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 15:1483896 PubMed39845783
2025
Applications
Unspecified application
Species
Unspecified reactive species
International journal of immunopathology and pharmacology 38:3946320241297342 PubMed39475763
2024
Applications
Unspecified application
Species
Unspecified reactive species
Heliyon 10:e37715 PubMed39315204
2024
Applications
Unspecified application
Species
Unspecified reactive species
Emerging microbes & infections 13:2366359 PubMed38855910
2024
Applications
Unspecified application
Species
Unspecified reactive species
Neoplasia (New York, N.Y.) 48:100960 PubMed38184887
2024
Applications
Unspecified application
Species
Unspecified reactive species
Aging 15:8113-8136 PubMed37595258
2023
Applications
Unspecified application
Species
Unspecified reactive species
Proceedings of the National Academy of Sciences of the United States of America 119: PubMed35027451
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com